This inventor holds 2 USPTO granted patents. Top assignee: Aventis Pharma S.a.. Active years: 2005-2006.
Company Filing History:
Years Active: 2005-2006
Title: Marc Antoine Perrin: Innovator in Pharmaceutical Chemistry
Introduction
Marc Antoine Perrin is a notable inventor based in Jouy en Josas, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of crystalline forms of complex compounds. His work has led to advancements in the treatment of bacterial infections.
Latest Patents
Marc Antoine Perrin holds 2 patents related to the crystalline forms of (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperidine-3-carboxylic acid. His latest patents include processes for preparing various forms of this compound, which are characterized by their unique powder X-ray diffraction patterns. These inventions also encompass pharmaceutical compositions and methods for treating bacterial infections using these crystalline forms.
Career Highlights
Marc Antoine Perrin is associated with Aventis Pharma S.A., where he has been instrumental in research and development. His innovative approaches have contributed to the advancement of pharmaceutical formulations and therapeutic methods.
Collaborations
Some of his notable coworkers include Sylvaine Lafont and Carole Neves, who have collaborated with him on various projects within the pharmaceutical sector.
Conclusion
Marc Antoine Perrin's contributions to pharmaceutical chemistry through his patents and collaborative efforts highlight his role as a key innovator in the field. His work continues to impact the development of effective treatments for bacterial infections.